Evidence map›Paper›PMID 42053099›Full record

ReviewFuture science OA2026

Novel male contraceptives.

Jacqueline Quinn, John J Reynolds-Wright

Abstract readReview
In one paragraph

Review in Future science OA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jacqueline QuinnCentre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh.
John J Reynolds-WrightCentre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Male contraception is relied upon by many couples around the world in the form of condoms, vasectomy, and withdrawal. Novel male contraceptives are a collection of interventions in development including hormonal, non-hormonal, immunological and reversible vas-occlusive methods. A large multinational trial of a novel hormonal contraceptive has recently concluded, and while the results are awaited, this narrative review discusses the field and potential methods on the horizon.

Indexed as

androgenhydrogelMale contraceptionprogestinsegesterone acetatetestosterone

Identifiers

PMID42053099
PMCPMC13134417

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.